Brokerages Set Kenvue Inc. (NYSE:KVUE) Price Target at $22.64

Kenvue Inc. (NYSE:KVUE) has earned a consensus rating of “Hold” from the twelve ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $22.64.

A number of research firms have recently issued reports on KVUE. Bank of America increased their price objective on shares of Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Tuesday, October 22nd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. UBS Group raised their price target on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. JPMorgan Chase & Co. raised their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Finally, Jefferies Financial Group began coverage on shares of Kenvue in a research report on Tuesday, September 24th. They issued a “buy” rating and a $27.00 price target on the stock.

Institutional Investors Weigh In On Kenvue

Several institutional investors and hedge funds have recently added to or reduced their stakes in KVUE. Advisors Asset Management Inc. purchased a new stake in Kenvue in the 1st quarter valued at about $206,000. Janus Henderson Group PLC increased its stake in shares of Kenvue by 53.7% during the 1st quarter. Janus Henderson Group PLC now owns 165,162 shares of the company’s stock worth $3,541,000 after purchasing an additional 57,679 shares during the last quarter. Atria Investments Inc increased its stake in shares of Kenvue by 20.0% during the 1st quarter. Atria Investments Inc now owns 112,194 shares of the company’s stock worth $2,408,000 after purchasing an additional 18,663 shares during the last quarter. Cetera Investment Advisers increased its stake in shares of Kenvue by 183.9% during the 1st quarter. Cetera Investment Advisers now owns 449,506 shares of the company’s stock worth $9,646,000 after purchasing an additional 291,179 shares during the last quarter. Finally, Cetera Advisors LLC increased its stake in shares of Kenvue by 202.0% during the 1st quarter. Cetera Advisors LLC now owns 212,097 shares of the company’s stock worth $4,552,000 after purchasing an additional 141,858 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

Shares of KVUE opened at $24.26 on Friday. The stock has a market capitalization of $46.51 billion, a P/E ratio of 44.11, a price-to-earnings-growth ratio of 2.19 and a beta of 1.36. The firm’s fifty day simple moving average is $22.96 and its two-hundred day simple moving average is $21.02. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue has a 12 month low of $17.67 and a 12 month high of $24.46.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The company had revenue of $3.90 billion for the quarter, compared to analysts’ expectations of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The business’s revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.31 EPS. As a group, analysts predict that Kenvue will post 1.07 EPS for the current year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th were paid a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.38%. Kenvue’s dividend payout ratio (DPR) is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.